Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 5c

Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.11, $0.05 better than the analyst estimate of $2.06. Revenue for the quarter came in at $2.09 billion versus the consensus estimate of $2.08 billion.

Financial Guidance

There continues to be uncertainty around the ongoing impact of COVID-19. Therefore, the Company is currently unable to quantify the expected impact on its results of operations, financial condition and cash flows, which could be material, for full year 2021 and is not providing financial guidance at this time.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance